A nurse prepares a syringe of the Sputnik V vaccine in a clinic in Moscow on December 28, 2020. Vladimir Gerdo / TASS / Getty Images

The Russian Gamaleya Institute, which developed the Sputnik V coronavirus vaccine, has applied for an emergency permit in the Philippines.

The Moscow-based company filed its application on Thursday, according to the Philippine news agency.

A day earlier, Gamaleya withdrew its application to conduct clinical trials in the country, according to CNN subsidiary CNN Philippines.

Gamaleya is the third vaccine manufacturer, along with Pfizer-BioNTech and Oxford-AstraZeneca, to apply for emergency approval in the Philippines.

According to CNN Philippines, it usually takes 21 days for the Philippine Food and Drug Administration to decide whether a drug or vaccine can be used in the country.

Last November, Russia said the Sputnik V vaccine was at least 91.4% effective and could be more than 95% effective according to data from phase 3 studies.